Estimating Medicare and Patient Savings From the Use of Bevacizumab for the Treatment of Exudative Age-related Macular Degeneration.
Sign Up to like & getrecommendations! Published in 2018 at "American journal of ophthalmology"
DOI: 10.1016/j.ajo.2018.04.008
Abstract: PURPOSE The Medicare cost savings from the use of bevacizumab in the United States for the treatment of exudative age-related macular degeneration (AMD) were estimated by replacing the use of bevacizumab with ranibizumab and aflibercept.… read more here.
Keywords: savings use; use bevacizumab; exudative age; treatment ... See more keywords
Cost savings from use of a neonatal sepsis calculator in Australia: A modelled economic analysis
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Paediatrics and Child Health"
DOI: 10.1111/jpc.15384
Abstract: To estimate the change in average cost and length of stay (LOS) for the neonatal birth admission resulting from use of the neonatal early‐onset sepsis (EOS) calculator compared to guideline‐based management, in an Australian perinatal… read more here.
Keywords: savings use; sepsis; use neonatal; calculator ... See more keywords